Get started
OBIO TECHNOLOGY (SHANGHAI) CORP LTDOBIO TECHNOLOGY (SHANGHAI) CORP LTDOBIO TECHNOLOGY (SHANGHAI) CORP LTD

OBIO TECHNOLOGY (SHANGHAI) CORP LTD

No trades
See on Supercharts
Overview
Financials
News Discussions Technicals Forecast Seasonals

688238 fundamentals

Key facts

Market capitalization—
Dividend yield (indicated)—
Price to earnings Ratio (TTM)—
Basic EPS (TTM)—
Founded—
Employees (FY)—
CEO—
Website—
About

Obio Technology Shanghai Corp. Ltd. is a biotechnology company. It focuses on providing gene therapy vector development, gene function research, CRO services such as drug target and efficacy research, and CDMO services such as process development and testing, IND-CMC pharmaceutical research, and GMP production of clinical samples for the research and development of genetic drugs. The company was founded on March 5, 2013 and is headquartered in Shanghai, China.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
688238 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company